TEV-1845

3 Biotechs That Just Announced Successful Phase 2 Trials
24/7 Wall St
Sun, 06/12/16 - 10:03 pm
clinical trials
TEV-1845
Teva Pharmaceutical
migraines
Sarepta
eteplirsen
Duchenne Muscular Dystrophy